“Boots on the ground” is an often overused phrase, but it’s an essential part of any health-care fraud investigation. Technology can do a lot to identify potential fraud, but field agents do the actual work of investigating. The Trump administration’s federal hiring freeze may lead to fewer agents and fewer fraud recoveries, Linda Baumann, an attorney with Arent Fox, recently told me.
The Trump executive order prevents government agencies from replacing investigators and attorneys lost to attrition, Baumann said. “Because fraud and abuse enforcement efforts bring significant amounts of money back to the federal government, I would expect funding ultimately to be restored, but it's hard to predict at this point, particularly since the HHS and DOJ secretaries haven't been confirmed,” she said.
I spoke with Baumann shortly after the release of the annual Health Care Fraud and Abuse Control program report for fiscal year 2016, which found that health-care fraud recoveries were up almost $1 billion from FY 2015, moving from $2.4 billion to $3.3 billion. While recoveries were up, the program’s return on investment dropped a bit. The report identified a 5-to-1 ROI over the past three years, meaning that every dollar spent on the program led to $5 in savings. The ROI in FY 2015 was 6.1-to-1.
Gejaa Gobena, an attorney with Hogan Lovells, told me that the jump in recoveries was significant, especially since recoveries had dropped from FY 2014 to FY 2015. Gobena said the current report showed that the decline was a mere “blip” and not evidence of any downward trend.
Gobena also said the HCFAC recoveries are being driven by smaller settlements, as opposed to one or two multibillion-dollar off-label pharmaceutical settlements.
Please read my full story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)